Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 65862-906

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 65862-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Ipratropiumalbuterol Fig1)

A line graph depicting the mean change in FEV1 (forced expiratory volume) over hours after dosing with ipratropium bromide and albuterol sulfate inhalation solution. The x-axis represents hours after dosing (0 to 8), and the y-axis represents liters of FEV1 change. Three lines show responses for albuterol, ipratropium, and their combination.*

FDA Label Image

Figure 1 (Ipratropiumalbuterol Fig2)

An instructional illustration showing how to assemble a respiratory inhalation solution device for Ipratropium Bromide and Albuterol Sulfate. The steps depict placing the mouthpiece onto the solution container and preparing the inhaler for use.*

FDA Label Image

Figure 2 (Ipratropiumalbuterol Fig3)

An instructional diagram illustrating the assembly of an inhalation solution device. It shows a hand holding a breath-actuated inhaler with a solution vial being inserted or attached, highlighting the preparation step for respiratory inhalation use of Ipratropium Bromide and Albuterol Sulfate solution.*

FDA Label Image

Figure 3 And 4 (Ipratropiumalbuterol Fig4)

Instructional illustration showing the use of a respiratory inhalation solution. The first panel depicts a person using a mouthpiece attached to the inhaler solution, while the second panel shows the person using a mask interface for inhalation, indicating two methods of administration for Ipratropium Bromide and Albuterol Sulfate solution.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg and 3 mg)

The label for Ipratropium Bromide and Albuterol Sulfate inhalation solution, USP, strength 0.5 mg/3 mg per 3 mL, features dosage and storage instructions. It notes the solution is a sterile unit-dose vial, packaged as one 3 mL vial per pouch. The label includes active and inactive ingredient information, storage conditions, and distributor details from Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg and 3 mg)

Label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, USP, with a strength of 0.5 mg/3 mg per 3 mL. The label indicates the product is for inhalation only, comes in a pouch containing five 3 mL sterile unit-dose vials, and is for prescription use only. Distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg and 3 mg)

Label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, USP 0.5 mg/3 mg per 3 mL by Aurobindo Pharma Limited. This prescription respiratory solution is provided in sterile unit-dose vials, with each carton containing 30 individually wrapped 3 mL vials. The label includes ingredient details, storage conditions, and pharmacist instructions.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg and 3 mg)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg/3 mg per 3 mL. The label states it is for inhalation only and supplied as sterile unit-dose vials. Each vial contains 0.5 mg ipratropium bromide and 3 mg albuterol sulfate, equivalent to 2.5 mg albuterol base. The label includes storage instructions, usage directions, pharmacist dispensing notes, distributor information (Aurobindo Pharma USA, Inc.), and a barcode. The solution is made in India.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg and 3 mg)

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, USP 0.5 mg/3 mg per 3 mL, a respiratory inhalation solution by Aurobindo Pharma Limited. The label states each vial contains 0.5 mg ipratropium bromide USP and 3 mg albuterol sulfate USP, equivalent to 2.5 mg albuterol base. The carton contains 12 pouches of five 3 mL sterile unit-dose vials (60 vials total). Distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Figure 1: Chemical Structure Of Albuterol Sulfate. (Ipratropiumalbuterol Str1)

Chemical structure of albuterol sulfate, shown as a molecular diagram including functional groups and sulfate counterions. The figure includes atomic connectivity and hydrogen atoms relevant to the compound's structure.*

FDA Label Image

Figure 2: Chemical Structure Of Ipratropium Bromide. (Ipratropiumalbuterol Str2)

Chemical structure of ipratropium bromide showing its molecular composition and arrangement, including bromide and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.